Abhishek Srivastava, MD, discusses the potential impact that UGN-103 might have on the treatment landscape for LG-IR-NMIBC.
Abhishek Srivastava, MD
Advertisement
Articles by Abhishek Srivastava, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves flibanserin for hypoactive sexual desire disorder in postmenopausal women
2
NMIBC treatment success: Why less frequent dosing and adherence matter
3
Jesse Mills, MD, explains the complications of multi-drug TRT
4
FDA approves niraparib plus abiraterone acetate with prednisone for BRCA2+ mCSPC
5
